Michael Halstead Intra Cellular Therapies, Inc. (ITCI) insider trading activity
Michael Halstead is EVP and General Counsel of Intra-Cellular Therapies, Inc.. Currently has a direct ownership of 0 shares of ITCI, which is worth approximately $0. The most recent transaction as insider was on Feb 18, 2022, when has been sold 11,139 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
0%
12M change
Total Value Held
$0
Michael Halstead Transaction History
MH
Michael Halstead
EVP and General Counsel
New York, NY